Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$7.17 - $18.55 $85,323 - $220,745
11,900 New
11,900 $197,000
Q2 2021

Aug 16, 2021

SELL
$46.47 - $63.93 $747,284 - $1.03 Million
-16,081 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$55.47 - $72.35 $630,638 - $822,547
11,369 Added 241.28%
16,081 $991,000
Q4 2020

Feb 16, 2021

BUY
$38.38 - $71.11 $180,846 - $335,070
4,712 New
4,712 $335,000
Q1 2020

May 15, 2020

SELL
$16.11 - $36.23 $287,966 - $647,611
-17,875 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$17.96 - $46.63 $321,035 - $833,511
17,875 New
17,875 $627,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.21B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.